In this webinar, we will introduce the importance of real-time multivariate analysis and its implementation methods against the backdrop of advancements in digitalization in biopharmaceutical manufacturing. As a means to achieve continuous process monitoring required by ICH Q9/Q10, we will discuss MSPC using SIMCA-online, explaining three functions: anomaly detection based on golden batches, future predictions, and optimal operation proposals. Furthermore, through case studies of SIMCA-online implementation in cell culture, purification, and formulation processes, we will demonstrate specific values such as yield improvement, loss avoidance, and accelerated decision-making. Finally, we will touch on the processes and organizational requirements from PoC to full-scale implementation, summarizing practical points for transitioning to data-driven manufacturing. 【Seminar Schedule】 ▪ Date: July 30 (Thursday) from 15:00 (approximately 30 minutes) ▪ Method: Webinar recorded broadcast [Japanese, Free] If you are unable to participate on the day, please register first. A viewing URL will be sent to you later. *We apologize, but participation from companies in the same industry and email addresses other than those of your organization is not permitted. Thank you for your understanding.

Registration for this webinar has closed. If you wish to view it, please contact us. We will send you the URL for the recorded video at a later date. Data has long been considered one of the most important assets for companies, but there are many challenges such as a shortage of digital talent, lack of collaboration within the company, and the speed of decision-making. At Sartorius, we provide "SIMCA" as software that can be used even by those who are not data analysis experts, enabling data visualization and rapid modeling to support enhanced decision-making and data sharing. 【Seminar Overview】 ▪ Date: December 8 (Thursday) from 3:00 PM (approximately 50 minutes) ▪ Method: Webinar recorded broadcast [Japanese, Free] *We sincerely apologize, but we ask that participants from other companies in the same industry, as well as those using email addresses not associated with their organization, refrain from participating. Thank you for your understanding.